FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer
Ontology highlight
ABSTRACT: This study is a randomized multi-center trial that will assess the effect of adding Selective Internal Radiation Therapy (SIRT), using SIR-Spheres microspheres, to a standard chemotherapy regimen of FOLFOX as first line therapy in patients with non-resectable liver metastases from primary colorectal adenocarcinoma.
Treatment with the biologic agent bevacizumab, if part of the standard of care at participating institutions, is allowed within this study at the discretion of the treating Investigator.
DISEASE(S): Colorectal Carcinoma,Neoplasm Metastasis,Carcinoma,Liver Metastases,Colon Cancer,Colorectal Cancer,Colorectal Neoplasms,Liver Neoplasms
PROVIDER: 2058912 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA